Tumor lysis syndrome is associated with all of he following laboratory feature except –
## **Core Concept**
Tumor lysis syndrome (TLS) is a life-threatening complication that occurs when a large number of cancer cells die rapidly, releasing their contents into the bloodstream. This condition is often associated with the treatment of cancers with high cell turnover rates, such as certain leukemias and lymphomas. The laboratory features of TLS include hyperuricemia, hyperphosphatemia, hypocalcemia, and hyperkalemia.
## **Why the Correct Answer is Right**
The correct answer, , is associated with tumor lysis syndrome through various mechanisms:
- **Hyperuricemia** results from the breakdown of nucleic acids (DNA and RNA) from lysed cancer cells into uric acid.
- **Hyperphosphatemia** occurs due to the release of phosphate from lysed cells.
- **Hypocalcemia** is a consequence of hyperphosphatemia, as phosphate binds to calcium, leading to its deposition in tissues as calcium phosphate.
- **Hyperkalemia** results from the release of potassium from lysed cells.
## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is actually one of the correct associations with TLS, hence not the answer we're looking for.
- **Option B:** Similarly, this is another correct association.
- **Option C:** Also a correct association, as TLS leads to an increase in phosphate levels.
- **Option D:** This option does not align with the typical laboratory features of TLS. Typically, TLS is associated with **hyperuricemia** (not hypouricemia), **hyperphosphatemia** (not hypophosphatemia), **hypocalcemia** (not hypercalcemia), and **hyperkalemia** (not hypokalemia).
## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is to identify patients at high risk for TLS before starting chemotherapy, particularly those with high tumor burden, certain types of leukemia or lymphoma, and pre-existing renal impairment. Early recognition and management, including aggressive hydration, uric acid lowering therapy (e.g., allopurinol or rasburicase), and management of electrolyte imbalances, are crucial.
## **Correct Answer:** .